190 related articles for article (PubMed ID: 27890708)
1. Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicity.
Ding X; Barodia SK; Ma L; Goldberg MS
Neurobiol Dis; 2017 Feb; 98():122-136. PubMed ID: 27890708
[TBL] [Abstract][Full Text] [Related]
2. P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity.
Kalogeropulou AF; Zhao J; Bolliger MF; Memou A; Narasimha S; Molitor TP; Wilson WH; Rideout HJ; Nichols RJ
Biochem J; 2018 Apr; 475(7):1271-1293. PubMed ID: 29519959
[TBL] [Abstract][Full Text] [Related]
3. Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP.
Ding X; Goldberg MS
PLoS One; 2009 Jun; 4(6):e5949. PubMed ID: 19536328
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.
Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998
[TBL] [Abstract][Full Text] [Related]
5. The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2.
Rudenko IN; Kaganovich A; Langston RG; Beilina A; Ndukwe K; Kumaran R; Dillman AA; Chia R; Cookson MR
Biochem J; 2017 Apr; 474(9):1547-1558. PubMed ID: 28320779
[TBL] [Abstract][Full Text] [Related]
6. Interplay between Leucine-Rich Repeat Kinase 2 (LRRK2) and p62/SQSTM-1 in Selective Autophagy.
Park S; Han S; Choi I; Kim B; Park SP; Joe EH; Suh YH
PLoS One; 2016; 11(9):e0163029. PubMed ID: 27631370
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 interferes with aggresome formation for autophagic clearance.
Bang Y; Kim KS; Seol W; Choi HJ
Mol Cell Neurosci; 2016 Sep; 75():71-80. PubMed ID: 27364102
[TBL] [Abstract][Full Text] [Related]
8. F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7.
Liu Y; Lear T; Zhao Y; Zhao J; Zou C; Chen BB; Mallampalli RK
Cell Death Dis; 2015 Feb; 6(2):e1630. PubMed ID: 25654763
[TBL] [Abstract][Full Text] [Related]
9. The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.
Wang L; Xie C; Greggio E; Parisiadou L; Shim H; Sun L; Chandran J; Lin X; Lai C; Yang WJ; Moore DJ; Dawson TM; Dawson VL; Chiosis G; Cookson MR; Cai H
J Neurosci; 2008 Mar; 28(13):3384-91. PubMed ID: 18367605
[TBL] [Abstract][Full Text] [Related]
10. LRRK2 Promotes Tau Accumulation, Aggregation and Release.
Guerreiro PS; Gerhardt E; Lopes da Fonseca T; Bähr M; Outeiro TF; Eckermann K
Mol Neurobiol; 2016 Jul; 53(5):3124-3135. PubMed ID: 26014385
[TBL] [Abstract][Full Text] [Related]
11. CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity.
Ko HS; Bailey R; Smith WW; Liu Z; Shin JH; Lee YI; Zhang YJ; Jiang H; Ross CA; Moore DJ; Patterson C; Petrucelli L; Dawson TM; Dawson VL
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2897-902. PubMed ID: 19196961
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants.
Verma M; Callio J; Otero PA; Sekler I; Wills ZP; Chu CT
J Neurosci; 2017 Nov; 37(46):11151-11165. PubMed ID: 29038245
[TBL] [Abstract][Full Text] [Related]
13. Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1.
Nucifora FC; Nucifora LG; Ng CH; Arbez N; Guo Y; Roby E; Shani V; Engelender S; Wei D; Wang XF; Li T; Moore DJ; Pletnikova O; Troncoso JC; Sawa A; Dawson TM; Smith W; Lim KL; Ross CA
Nat Commun; 2016 Jun; 7():11792. PubMed ID: 27273569
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 Phosphorylation.
Nichols RJ
Adv Neurobiol; 2017; 14():51-70. PubMed ID: 28353278
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32.
Gonzalez-Cano L; Menzl I; Tisserand J; Nicklas S; Schwamborn JC
Mol Neurobiol; 2018 Apr; 55(4):3490-3498. PubMed ID: 28508149
[TBL] [Abstract][Full Text] [Related]
16. LRRK2 dephosphorylation increases its ubiquitination.
Zhao J; Molitor TP; Langston JW; Nichols RJ
Biochem J; 2015 Jul; 469(1):107-20. PubMed ID: 25939886
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effect of the LRRK2 Kinase Inhibitor PF-06447475 in Human Nerve-Like Differentiated Cells Exposed to Oxidative Stress Stimuli: Implications for Parkinson's Disease.
Mendivil-Perez M; Velez-Pardo C; Jimenez-Del-Rio M
Neurochem Res; 2016 Oct; 41(10):2675-2692. PubMed ID: 27394417
[TBL] [Abstract][Full Text] [Related]
18. LRRK2 regulates endoplasmic reticulum-mitochondrial tethering through the PERK-mediated ubiquitination pathway.
Toyofuku T; Okamoto Y; Ishikawa T; Sasawatari S; Kumanogoh A
EMBO J; 2020 Jan; 39(2):e100875. PubMed ID: 31821596
[TBL] [Abstract][Full Text] [Related]
19. Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation.
Han KA; Shin WH; Jung S; Seol W; Seo H; Ko C; Chung KC
Hum Mol Genet; 2017 Jan; 26(1):1-18. PubMed ID: 27798112
[TBL] [Abstract][Full Text] [Related]
20. Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosis.
Heaton GR; Landeck N; Mamais A; Nalls MA; Nixon-Abell J; Kumaran R; Beilina A; Pellegrini L; Li Y; ; Harvey K; Cookson MR
Neurobiol Dis; 2020 Jul; 141():104948. PubMed ID: 32434048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
